Physician profile
Jill A Brown
NPI 1316432032
$3,257.99
in general payments reported to CMS, 2019-2025
14 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $551 · 2023: $747 · 2024: $661 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,351 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,350.84 |
| Education | $144.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $541.14 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Teva Pharmaceuticals USA, INC. | $469.93 | 2022-2025 | Uzedy, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $389.87 | 2021-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $383.03 | 2021-2024 | Invega Sustenna, Spravato, Invega |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $311.59 | 2021-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $290.14 | 2021-2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $248.21 | 2024-2025 | Cobenfy |
| Abbvie INC. | $176.87 | 2021-2025 | |
| Axsome Therapeutics, INC. | $150.97 | 2023-2025 | Auvelity |
| Alkermes, INC. | $143.95 | 2023-2025 | Aristada, Lybalvi |
| Boston Scientific Corporation | $51.22 | 2024 | Truselect |
| Indivior INC. | $47.67 | 2021-2023 | Perseris |
| Lundbeck LLC | $36.36 | 2023-2024 | Rexulti |
| Noven Pharmaceuticals, INC. | $17.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.